Who
Elizabeth Crowley
Sr. VP & Cpdo
Company insider
Files Form 4 as: Sr. VP & Cpdo, Celldex Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $3.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jun 2017
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $311K30,000 at $10.38 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $1.0M30,000 at $34.87 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $78K7,500 at $10.38 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $68K7,500 at $9.02 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $526K15,000 at $35.06 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —34,445 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —8,500 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $96K34,445 at $2.78 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $77K8,500 at $9.02 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $1.3M38,597 at $33.64 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 8 Dec 2021filed 10 Dec 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.